Martha Goldberg  Aronson net worth and biography

Martha Aronson Biography and Net Worth

Martha Goldberg Aronson Jr. serves as Independent Director of the Company. Ms. Goldberg Aronson has been a member of our Board since February 2017. Ms. Goldberg Aronson served as Executive Vice President of Strategic Planning at Ecolab, Inc., a specialty chemical company, from November 2015 to April 2016, and previously served as Ecolab’s Executive Vice President and President-Global Healthcare, from September 2012 to November 2015. Prior to Ecolab, Ms. Goldberg Aronson served as Senior Vice President and President, North America, of Hill-Rom Holdings, Inc., a leading worldwide manufacturer and provider of medical technologies and related services for the health-care industry, since August 2010. Before joining Hill-Rom, she served as Senior Vice President at Medtronic, Inc., from March 2008 to November 2009, and in various other domestic and international management positions with Medtronic, since 1991. She is also a director of Methode Electronics, Inc., CONMED Corporation and Clinical Innovations, LLC, and previously served as a director of Hutchinson Technology from 2010 to 2016, when it was acquired.

What is Martha Goldberg Aronson's net worth?

The estimated net worth of Martha Goldberg Aronson is at least $150,000.00 as of May 10th, 2021. Ms. Aronson owns 7,500 shares of Cardiovascular Systems stock worth more than $150,000 as of April 25th. This net worth approximation does not reflect any other assets that Ms. Aronson may own. Learn More about Martha Goldberg Aronson's net worth.

How do I contact Martha Goldberg Aronson?

The corporate mailing address for Ms. Aronson and other Cardiovascular Systems executives is 1225 OLD HWY 8 NW, ST. PAUL MN, 55112. Cardiovascular Systems can also be reached via phone at (651) 259-1600 and via email at [email protected]. Learn More on Martha Goldberg Aronson's contact information.

Has Martha Goldberg Aronson been buying or selling shares of Cardiovascular Systems?

Martha Goldberg Aronson has not been actively trading shares of Cardiovascular Systems in the last ninety days. Most recently, on Monday, February 7th, Martha Goldberg Aronson bought 2,500 shares of Cardiovascular Systems stock. The stock was acquired at an average cost of $18.43 per share, with a total value of $46,075.00. Learn More on Martha Goldberg Aronson's trading history.

Who are Cardiovascular Systems' active insiders?

Cardiovascular Systems' insider roster includes Martha Aronson (Director), Erik Paulsen (Director), Jeffrey Points (CFO), Rhonda Robb (COO), and Scott Ward (CEO). Learn More on Cardiovascular Systems' active insiders.

Martha Goldberg Aronson Insider Trading History at Cardiovascular Systems

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2022Buy2,500$18.43$46,075.00View SEC Filing Icon  
5/10/2021Buy1,500$34.59$51,885.007,500View SEC Filing Icon  
8/13/2020Buy3,000$32.22$96,660.006,000View SEC Filing Icon  
11/1/2018Buy3,000$28.72$86,160.003,000View SEC Filing Icon  
See Full Table

Martha Goldberg Aronson Buying and Selling Activity at Cardiovascular Systems

This chart shows Martha Goldberg Aronson's buying and selling at Cardiovascular Systems by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cardiovascular Systems Company Overview

Cardiovascular Systems logo
Cardiovascular Systems, Inc. is a medical device company, which engages in the development and commercialization of solutions for treating vascular and coronary disease. It offers orbital atherectomy systems for both peripheral and coronary commercial applications. The company was founded in 1989 and is headquartered in St. Paul, MN.
Read More

Today's Range

Now: $20.00
Low: $20.00
High: $20.00

50 Day Range

MA: $19.98
Low: $19.87
High: $20.00

2 Week Range

Now: $20.00
Low: $12.26
High: $20.57

Volume

4,300 shs

Average Volume

765,906 shs

Market Capitalization

$843.96 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.74